Phase 2
Completed N=183
Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease
Source: ClinicalTrials.gov NCT00667004 ↗Enrolled (actual)
183
Serious AEs
0.5%
Results posted
Sep 2020
Primary outcomePrimary: Mean Change From Baseline in Lacrimation Assessed by Schirmer's Test — 3.02; 2.15; 2.35; 1.35 mm
Summary
Efficacy study of ecabet ophthalmic solution in dry eye disease
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Change From Baseline in Lacrimation Assessed by Schirmer's Test |
3.02; 2.15; 2.35; 1.35 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosed with dry eye disease
Exclusion Criteria
- Dry eye disease secondary to surgery
Data sourced from ClinicalTrials.gov (NCT00667004). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.